June 21, 2017 — RadNet Inc. and Medic Vision Imaging Solutions Ltd. announced that RadNet has acquired an equity stake ...
The Department of Human Oncology at the University of Wisconsin-Madison has entered into an agreement with RaySearch to pioneer the RayCare oncology information system (OIS). The new system will be used in the department’s multidisciplinary approach to cancer care and its focus on cutting-edge techniques.
The Radiological Society of North America (RSNA) Research and Education (R&E) Foundation will fund $4 million in grants this year, achieving a funding rate of 30 percent of all grant applications.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
In an article published in the June 2017 issue of The Journal of Nuclear Medicine, researchers assert that exposure to medical imaging radiation not only doesn’t increase an adult person’s risk of getting cancer, it doesn’t increase a child’s risk. According to the authors, the long-held belief that even low doses of radiation, such as those received in diagnostic imaging, increase cancer risk is based on an inaccurate, 70-year-old hypothesis and leads to unnecessary fear and misdiagnoses.
June 20, 2017 — Carestream Health will show the DRX-Revolution Nano Mobile X-ray system, which pending U.S. Food and ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Alex Towbin, M.D., Neil D. Johnson Chair of Radiology Informatics at Cincinnati Children's Hospital, discusses the growing importance of translational and reproducible research in medical imaging informatics at SIIM 2017.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (18F-NaF) followed by quantitative scanning significantly improves image quality and detection of bone metastases at a lower dose, according to new research. The research was presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 10-14 in Denver.
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France, is providing advanced radiation treatments to cancer patients using the smart Radixact Treatment Delivery System, the first to be installed in France. The IUCT Oncopole began treating patients in January with this new system, designed to deliver image-guided intensity-modulated radiation therapy (IG-IMRT), an extremely precise form of radiation therapy.
June 20, 2017 — Breast-conserving surgery (BCS) is the primary treatment for early-stage breast cancer, but more ...
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer patients advanced radiation therapy with the ViewRay MRIdian Linac system. The system uses a U.S. Food and Drug Administration (FDA)-approved real-time magnetic resonance imaging (MRI) and linear accelerator delivery for more precise and accurate radiation treatment.
The tenth special edition Image Wisely Radiation Safety Case is now available to help radiologists, imaging technologists and medical physicists assess their understanding of important radiation safety concepts, including dose monitoring and management.
Fujifilm Medical Systems U.S.A. Inc. presented its comprehensive Synapse Enterprise Imaging portfolio at the 2017 Annual Meeting of the Society for Imaging Informatics in Medicine (SIIM), held June 1-3 in Pittsburgh. The annual meeting featured advancements in medical imaging, cutting-edge scientific research and enterprise imaging thought leaders.
Having the most efficient clinical workflows with enhanced diagnostic capabilities is a major goal for clinicians and ...
June 16, 2017 — The U.S. Food and Drug Administration (FDA) has expanded the indication for GE Healthcare’s imaging ...
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Vida 3 Tesla (3T) magnetic resonance imaging (MRI) scanner from Siemens Healthineers, which features new BioMatrix technology that addresses inherent anatomical and physiological differences among patients, as well as user variability.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
RamSoft announced its distribution partnership with KenQuest Medical. With RamSoft’s PowerServer and Gateway solutions, KenQuest Medical will offer clinics a software solution that can be customized to fit their workflow, enhance patient care, and ensure minimal downtime to fulfill their image management, storage, and distribution needs from a trusted source at competitive prices.
Researchers from the University of Luxembourg, in cooperation with the University of Strasbourg, have developed a computational method that could be used to guide surgeons during brain surgery.
During the first quarter of 2017, Black Book surveyed 140 chief information officers (CIOs), 159 chief financial officers (CFOs) and 448 hospital managers involved in planning and executing population health initiatives within the next 12 months. Ninety percent of the collective respondents revealed that future population health management (PHM) systems will essentially be projected to perform as next-generation patient accounting systems.
An estimated one in seven American men will be affected by prostate cancer in their lifetime. Prostate-specific molecular imaging gives these men a fighting chance, especially if their cancer returns, according to research revealed at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
In the battle against metastatic prostate cancer, the removal of lymph node metastases using image-guided surgery may have a high clinical impact on outcomes. Researchers at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrated preclinically that dual-labeled PSMA-inhibitors based on PSMA-11 enhance preoperative staging, using PET/CT followed by fluorescence-guided surgery.
Pancreatic cancer is associated with bleak five-year survival rates and limited treatment options, but new research is offering hope. A first-in-human study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates the feasibility and safety of the novel human monoclonal antibody HuMab-5B1 with highly specific targeting for the cancer antigen (CA) 19-9, which is expressed on pancreatic tumors and a variety of other malignancies, including small cell lung cancer and tumors of the gastrointestinal system.